Mavrilimumab Biosimilar – Anti-CSF2RA, CD116 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameMavrilimumab Biosimilar - Anti-CSF2RA, CD116 mAb - Research Grade
SourceCAS 1085337-57-0
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsMavrilimumab,CAM-3001,CSF2RA, CD116 ,anti-CSF2RA, CD116
ReferencePX-TA1241
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-lambda2
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Mavrilimumab Biosimilar – Anti-CSF2RA, CD116 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Granulocyte-macrophage colony-stimulating factor receptor subunit alpha(CSF2RA)
Antigen

Granulocyte-macrophage colony-stimulating factor receptor subunit alpha(CSF2RA)

PX-P4584 210€
CD116 / CSF2RA, C-His, recombinant protein
Antigen

CD116 / CSF2RA, C-His, recombinant protein

PX-P5550 385€
Stable Isotope Labelled Mavrilimumab Biosimilar – Anti-CSF2RA/CD116  mAb – Research Grade
SIL

Stable Isotope Labelled Mavrilimumab Biosimilar – Anti-CSF2RA/CD116 mAb – Research Grade

PX-TA1241-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products